This review focuses on reverse cardio‐oncology and highlights clinical studies, meta‐analyses, and cohorts that have evaluated cancer risk in patients with cardiovascular disease and the risk associated with treatments of cardiovascular disease. In addition, this article summarizes mechanisms of actions that mediate the cross-talk between cancer and cardiovascular disease